Higher frequency of secretor phenotype in O blood group – its benefits in prevention and/or treatment of some diseases

References

• WatkinsWMThe ABO blood group system: historical backgroundTransfus Med200111424326511532183
   PubMed Web of Science ®Google Scholar
• HenrySMThe biosynthetic pathway for blood group related glycoconjugates in the human gastrointestinal tract; a map of pathogen receptors and insights into ABOPaper Presented at NZIMLS Annual Scientific Meeting2001Auckland, New Zealand
   Google Scholar
• JaffMSO’BriainDSExcess of blood group B in primary myelofibrosisVox Sang19875232502533111093
   PubMed Web of Science ®Google Scholar
• D’AdamoPJKellyGSMetabolic and immunologic consequences of ABH secretor and Lewis subtype statusAltern Med Rev20016439040511578255
   PubMedGoogle Scholar
• SlomianyBLSlomianyAABH-blood-group antigens and glycolipid of human salivaEur J Biochem1978851249254639818
   PubMedGoogle Scholar
• GreenwellPBlood group antigens: molecules seeking a function?Glycoconj J19971421591739111133
   PubMed Web of Science ®Google Scholar
• HenrySMReview: phenotyping for Lewis and secretor histo-blood group antigensImmunohaematology1996125161
   Google Scholar
• DanielsGHuman Blood Groups2nd edOxford (UK)Blackwell Science2002770
   Google Scholar
• HenrySOriolRSamuelssonBLewis histo-blood group system and associated secretory phenotypesVox Sang19956931661828578728
   PubMed Web of Science ®Google Scholar
• HenrySBennyAWoodsfieldDInvestigation of Lewis phenotypes in Polynesians: evidence for a weak secretor phenotypeVox Sang199058161662316213
   PubMed Web of Science ®Google Scholar
• JaffMSBilbasFAHFrequency of the ABH blood group antigen secretors among kurdsZanco J Med Sci20071121519
   Google Scholar
• RaceRRSangerRBlood Groups in Man6th edOxford (UK)Blackwell1975323349
   Google Scholar
• MeeranKBloomSRLewis phenotypes, insulin resistance, and risk of ischemic heart disease (editorial)Br Heart J19947143053068198876
   PubMedGoogle Scholar
• HarmeningDMModern Blood Banking and Transfusion Practices4th edPhiladelphia (PA)F.A. Davis Company199990158
   Google Scholar
• de MattosLCCintraJRSanchesFEAlves da SilvaRdeCRuizMAMoreiraHWABO, Lewis, secretor and non-secretor phenotypes in patients infected or uninfected by the Helicobacter pylori bacillusSao Paulo Med J20021202555811994774
   PubMedGoogle Scholar
• GarrattyGBlood groups and disease: a historical perspectiveTransfus Med Rev200014429130111055074
   PubMed Web of Science ®Google Scholar
• ShararaAIAbdul-BakiHEl-HajjIKreidiehNKfoury BazEMAssociation of gastroduodenal disease phenotype with ABO blood group and helicobacter pylori virulence-specific serotypesDig Liver Dis2006381182983316931196
   PubMedGoogle Scholar
• CampiCEscovichLValdésVSecretor status and ABH antigens expression in patients with oral lesionsMed Oral Patol Oral Cir Bucal2007126E43143417909508
   PubMedGoogle Scholar
• DabelsteenEGaoSABO blood-group antigens in oral cancerJ Dent Res2005841212815615870
   PubMed Web of Science ®Google Scholar
• RootsIDrakoulisNPlochMDebrisoquine hydroxylation phenotype, acetylation pheno-type, and ABO blood groups as genetic host factors of lung cancer riskKlin Wochenschr198866Suppl 1187972846954
   PubMedGoogle Scholar
• RobertsTEHasletonPSwindellRLawsonRBlood groups and lung cancerBr J Cancer19885822783166917
   PubMed Web of Science ®Google Scholar
• FujitaniNLiuYTodaSShirouzuKOkamuraTKimuraHExpression of H type 1 antigen of ABO histo-blood group in normal colon and aberrant expressions of H type 2 and H type 3/4 antigens in colon cancerGlycoconj J200017533133811261842
   PubMed Web of Science ®Google Scholar
• HendersonJSeagroattVGoldacreMOvarian cancer and ABO blood groupsJ Epidemiol Community Health19934742872898228763
   PubMed Web of Science ®Google Scholar
• VioqueJWalkerAMPancreatic cancer and ABO blood types: a study of cases and controlsMed Clin (Barc)199196207617641875761
   PubMed Web of Science ®Google Scholar
• WolpinBMKraftPGrossMPancreatic cancer risk and ABO blood group alleles: results from the Pancreatic Cancer Cohort ConsortiumCancer Res20097031015102320103627
   PubMed Web of Science ®Google Scholar
• OishiKOkadaKYoshidaOCase-control study of prostatic cancer in Kyoto, Japan: demographic and some lifestyle risk factorsProstate19891421171222710690
   PubMed Web of Science ®Google Scholar
• NakataSSatoJOhtakeNImaiKYamanakaHEpidemiological study of risk factors for bladder cancerHinyokika Kiyo199541129699778578986
   PubMedGoogle Scholar
• AndersonDEHaasCBlood type A and familial breast cancerCancer1984549184518496478419
   PubMed Web of Science ®Google Scholar
• JanardhanaVPropertDNGreenREABO blood groups in hematologic malignanciesCancer Genet Cytogenet19915111131201984838
   PubMedGoogle Scholar
• BeckmanLAngqvistKAOn the mechanism behind the association between ABO blood groups and gastric carcinomaHum Hered19873731401433583294
   PubMed Web of Science ®Google Scholar
• DippoldWSteinbornAMeyer zum BuschenfeldeKHThe role of the Thomsen-Friedenreich antigen as a tumor-associated moleculeEnviron Health Perspect1990882552572272320
   PubMed Web of Science ®Google Scholar
• SpringerGFT and Tn, general carcinoma autoantigensScience19842244654119812066729450
   PubMed Web of Science ®Google Scholar
• Al-MehdiABTozawaKFisherABShientagLLeeAMuschelRJIntravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasisNat Med20006110010210613833
   PubMed Web of Science ®Google Scholar
• AvichezerDSpringerGFSchechterBArnonRImmunoreactivities of polyclonal and monoclonal anti-T and anti-Tn antibodies with human carcinoma cells, grown in vitro and in a xenograft modelInt J Cancer1997721119127 Erratum appears in Int J Cancer. 1997; 72(5):9189212232
   PubMed Web of Science ®Google Scholar
• ChoufaniGNagyNSaussezSThe levels of expression of galectin-1, galectin-3, and the Thomsen-Friedenreich antigen and their binding sites decrease as clinical aggressiveness increases in head and neck cancersCancer199986112353236310590378
   PubMed Web of Science ®Google Scholar
• BlackRELevineMMClementsMLHughesTO’DonnellSAssociation between O blood group and occurrence and severity of diarrhoea due to Escherichia coliTrans R Soc Trop Med Hyg19878111201283127953
   PubMed Web of Science ®Google Scholar
• KurtenkovOKlaamasKMiljukhinaLThe lower level of natural anti-Thomsen-Friedenreich antigen (TFA) agglutinins in sera of patients with gastric cancer related to ABO(H) blood-group phenotypeInt J Cancer19956067817857896445
   PubMed Web of Science ®Google Scholar
• HanssonLENyrénOHsingAWThe risk of stomach cancer in patients with gastric or duodenal ulcer diseaseN Engl J Med199633542422498657240
   PubMed Web of Science ®Google Scholar
• Rittenhouse-OlsonKJAA-F11 extending the life of mice with breast cancerExpert Opin Biol Ther20077792392817665983
   PubMed Web of Science ®Google Scholar
• WangWSLinJKLinTCPlasma von Willebrand factor level as a prognostic indicator of patients with metastatic colorectal carcinomaWorld J Gastroenterol200511142166217015810086
   PubMed Web of Science ®Google Scholar
• O’DonnellJBoultonFEManningRALaffanMAGenotype at the secretor blood group locus is a determinant of plasma von Willebrand factor levelBr J Haematol2002116235035611841438
   PubMed Web of Science ®Google Scholar